Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] NLMUID: 101140988"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 6808
Tytuł:
Diagnostic effectiveness of [ F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study.
Autorzy:
Bottoni G; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Mura delle Cappuccine 14, 16128, Italy.
Fiz F; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Mura delle Cappuccine 14, 16128, Italy. .
Puntoni M; Clinical and Epidemiological Research Unit, University Hospital of Parma, Parma, Italy.
Matteucci F; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST)- Dino Amadori, Meldola, Italy.
Monti M; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST)- Dino Amadori_, Meldola, Italy.
DeCensi A; Department of Medicine and Oncology, E.O. 'Ospedali Galliera', Genoa, Italy.
Nanni O; Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo studio e la cura dei tumori, IRST, Meldola, Italy.
Brain E; Department of Clinical Research & Medical Oncology, Institut Curie (Hôpital René Huguenin), St Cloud, France.
Alberini JL; Nuclear Medicine Department Centre Georges-Francois Leclerc, 1 rue du Pr Marion, 21079, Dijon Cedex, France.
Dib B; Nuclear Medicine Unit, AOU Maggiore della Carità, Novara, Italy.
Sacchetti G; Nuclear Medicine Unit, AOU Maggiore della Carità, Novara, Italy.
Trimboli P; Clinic of Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
Treglia G; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500, Bellinzona, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, 1015, Lausanne, Switzerland.
Harbeck N; Breast Centre, Department of Obstetrics and Gynaecology, LMU University Hospital, Munich, Germany.
Sola S; Pathology Unit, E.O. 'Ospedali Galliera', Genoa, Italy.
Gennari A; Department of Translational Oncology, University of Eastern Piedmont, Novara, Italy.
Piccardo A; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Mura delle Cappuccine 14, 16128, Italy.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2477-2485. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Multicenter Study; Journal Article; Comment
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Humans ; Female ; Positron Emission Tomography Computed Tomography/methods ; Receptors, Estrogen ; Prospective Studies ; Fluorodeoxyglucose F18 ; Estradiol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
Autorzy:
Wang J; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Ge J; Department of Nuclear Medicine/PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai, 200235, China.
Jin L; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Deng B; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Tang W; Department of Radiology, Huashan Hospital, Shanghai, 200040, China.
Yu H; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Zhang X; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Liu X; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Xue L; Department of Nuclear Medicine, the Second Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Zuo C; Department of Nuclear Medicine/PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai, 200235, China. .
Chen X; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. .; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. .; Human Phenome Institute, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2394-2408. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalitis*/diagnostic imaging
Glioma*
Autoimmune Diseases of the Nervous System*
Humans ; Neuroinflammatory Diseases ; Leucine ; Intracellular Signaling Peptides and Proteins ; Seizures ; Positron-Emission Tomography/methods ; Receptors, GABA
SCR Disease Name:
Hashimoto's encephalitis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Autorzy:
Spohn SKB; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany. .; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany. .; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany. .
Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Ruf J; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Mix M; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Benndorf M; Department of Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bamberg F; Department of Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Makowski MR; Department of Radiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Kirste S; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
Rühle A; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
Nouvel J; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
Sprave T; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
Vogel MME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Galitsnaya P; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Gschwend JE; Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Gratzke C; Department of Urology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Stief C; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Löck S; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.
Zwanenburg A; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.; German Cancer Consortium (DKTK) Partner Site Dresden, Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Bernhardt D; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Nekolla SG; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Li M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Radiation Medicine, Helmholtz Zentrum München, Munich, Germany.
Eiber M; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Unterrainer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Grosu AL; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
Zamboglou C; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Oncology Center, European University of Cyprus, Limassol, Cyprus.
Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Radiation Medicine, Helmholtz Zentrum München, Munich, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2537-2547. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Gallium Radioisotopes*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Male ; Humans ; Gallium Isotopes ; Positron Emission Tomography Computed Tomography/methods ; Prostatectomy ; Neoplasm Recurrence, Local/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post Lu-PSMA617 setting.
Autorzy:
Song H; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Ferri V; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Duan H; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Aparici CM; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Davidzon G; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Franc BL; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Moradi F; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Nguyen J; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Shah J; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA.
Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA, 94305, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2250-2257. Date of Electronic Publication: 2023 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Organometallic Compounds*/therapeutic use
Humans ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Feasibility Studies ; Retrospective Studies ; Octreotide/therapeutic use ; Positron-Emission Tomography/methods ; Tomography, Emission-Computed, Single-Photon/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[  Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma.
Autorzy:
Guo W; Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen Cancer CenterXiamen, China.
Chen Y; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
He X; Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen Cancer CenterXiamen, China.
Fu H; Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen Cancer CenterXiamen, China.
Huang J; Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen Cancer CenterXiamen, China.
Chen H; Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen Cancer CenterXiamen, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (9), pp. 2910-2911. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Insulinoma*/diagnostic imaging
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/pathology
Organometallic Compounds*
Humans ; Positron Emission Tomography Computed Tomography ; Exenatide ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PD-L1 - targeted magnetic fluorescent hybrid nanoparticles: Illuminating the path of image-guided cancer immunotherapy.
Autorzy:
Li X; Departments of Radiology and Medical Physics, University of WI - Madison, Madison, WI, USA.
Younis MH; Departments of Radiology and Medical Physics, University of WI - Madison, Madison, WI, USA.
Wei W; Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Cai W; Departments of Radiology and Medical Physics, University of WI - Madison, Madison, WI, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2240-2243.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Neoplasms*/diagnostic imaging
Neoplasms*/therapy
Nanoparticles*
Humans ; B7-H1 Antigen ; Immunotherapy ; Magnetic Phenomena ; Cell Line, Tumor
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[ F]mFBG long axial field of view PET-CT without general anaesthesia reveals concise extension of neuroblastoma in a 9-month-old boy.
Autorzy:
Borgwardt L; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. .
Brok JS; Department of Paediatrics, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Andersen KF; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Madsen J; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Gillings N; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Fosbøl MØ; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Denholt CL; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Wehner PS; Department of Paediatrics, Odense University Hospital, Odense, Denmark.
Enevoldsen LH; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Oturai P; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Czyzewska D; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Johannesen HH; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Højgaard L; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Petersen IN; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Sørensen LS; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Schulze C; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Saxtoft ES; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Andersen FL; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Fischer BM; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2563-2564. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*
Neuroblastoma*/diagnostic imaging
Male ; Humans ; Infant ; Positron-Emission Tomography ; Anesthesia, General ; Radiopharmaceuticals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Trigeminal nerve perineural invasion by an adenoid cystic carcinoma of the maxillary sinus, detected by Ga-PSMA.
Autorzy:
Novoselska N; Nuclear Medicine Department, Acibadem City Clinic UMBAL Mladost, #66A Tsarigradsko Shosse, Sofia, Bulgaria.
Nedev N; Radiation Oncology Department, Acibadem City Clinic UMBAL Mladost, Sofia, Bulgaria.
Mateva G; Nuclear Medicine Department, Acibadem City Clinic UMBAL Mladost, #66A Tsarigradsko Shosse, Sofia, Bulgaria.
Bochev P; Nuclear Medicine Department, Acibadem City Clinic UMBAL Mladost, #66A Tsarigradsko Shosse, Sofia, Bulgaria. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2561-2562. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Adenoid Cystic*/diagnostic imaging
Humans ; Maxillary Sinus/pathology ; Trigeminal Nerve/pathology ; Gallium Radioisotopes ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
F-FDG PET/CT findings in autopsy confirmed a case of ischemic cardiac disease at an early stage.
Autorzy:
Manabe O; Department of Radiology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Tsukui T; Department of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Yoshimura K; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Oshiro H; Department of Pathology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Oyama-Manabe N; Department of Radiology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan. .
Aikawa T; Department of Radiology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Takahashi K; Department of Radiology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Sakakura K; Department of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Fujita H; Department of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama, 330-8503, Japan.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2224-2225. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Myocardial Ischemia*/diagnostic imaging
Coronary Artery Disease*
Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography ; Autopsy ; Positron-Emission Tomography ; Radiopharmaceuticals ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction to: Clinical prospective study of Gallium 68 (68Ga)-labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma.
Autorzy:
Jinghua L; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Kui X; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Deliang G; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Bo L; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Qian Z; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Haitao W; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Yaqun J; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Dongde W; Department of Hepatobiliary and Pancreatic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Xigang X; Department of Hepatobiliary Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Ping J; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Shengli T; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Zhiyong Y; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Yueming H; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
Zhonglin Z; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. .; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China. .
Yong H; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China. .; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. .
Yufeng Y; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. .; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China. .; TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2230.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Direct co-registration of [ F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study.
Autorzy:
Debacker JM; Department of Head and Skin, Ghent University, Ghent, Belgium. .; Department of Head and Neck Surgery, Ghent University Hospital, Ghent, Belgium. .; Department of Nuclear Medicine, UZ Brussel, Brussels, Belgium. .; In vivo Cellular and Molecular Imaging Laboratory (ICMI), Vrije Universiteit Brussel, Brussels, Belgium. .; Cancer Research Institute Ghent, Ghent, Belgium. .
Maris L; Department of Electronics and Information Systems, Ghent University, Ghent, Belgium.; XEOS Medical, Ghent, Belgium.
Cordier F; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
Creytens D; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Pathology, Ghent University Hospital, Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Deron P; Department of Head and Skin, Ghent University, Ghent, Belgium.; Department of Head and Neck Surgery, Ghent University Hospital, Ghent, Belgium.
Descamps B; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Electronics and Information Systems, Ghent University, Ghent, Belgium.; INFINITY Lab, Ghent University, Ghent, Belgium.
D'Asseler Y; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Medical Imaging, Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
De Man K; Department of Medical Imaging, Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
Keereman V; Department of Electronics and Information Systems, Ghent University, Ghent, Belgium.; XEOS Medical, Ghent, Belgium.
Libbrecht S; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.
Schelfhout V; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Medical Imaging, Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
Van de Vijver K; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Pathology, Ghent University Hospital, Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Vanhove C; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Electronics and Information Systems, Ghent University, Ghent, Belgium.; INFINITY Lab, Ghent University, Ghent, Belgium.
Huvenne W; Department of Head and Skin, Ghent University, Ghent, Belgium.; Department of Head and Neck Surgery, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2127-2139. Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Fluorodeoxyglucose F18*
Neoplasms*
Humans ; Positron Emission Tomography Computed Tomography ; Radiopharmaceuticals ; Feasibility Studies ; Positron-Emission Tomography/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Astatine-211 for PSMA-targeted α-radiation therapy of micrometastatic prostate cancer: a sustainable approach towards precision oncology.
Autorzy:
Chakravarty R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India. .; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India. .
Lan X; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Key Laboratory of Molecular Imaging, Wuhan, China.
Chakraborty S; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
Cai W; Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 1844-1847.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Astatine*
Prostatic Neoplasms*/radiotherapy
Humans ; Male ; Antigens, Surface ; Neoplasm Recurrence, Local ; Precision Medicine
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diffusely increased breast uptake of [ F]AlF-NOTA-FAPI-04 related to menstrual status in a patient with papillary thyroid cancer.
Autorzy:
He T; Department of Nuclear Medicine, Panzhihua Central Hospital, Panzhihua, 617000, China.; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li X; Department of Nuclear Medicine, Panzhihua Central Hospital, Panzhihua, 617000, China.
Liang C; Department of Nuclear Medicine, Panzhihua Central Hospital, Panzhihua, 617000, China.
Wu J; Department of Nuclear Medicine, Panzhihua Central Hospital, Panzhihua, 617000, China.
Cai H; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2228-2229. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Heterocyclic Compounds, 1-Ring*
Thyroid Neoplasms*/diagnostic imaging
Humans ; Thyroid Cancer, Papillary/diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Gallium Radioisotopes ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primates.
Autorzy:
Chen B; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Ojha DP; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Toyonaga T; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Tong J; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Pracitto R; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Thomas MA; Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
Liu M; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Kapinos M; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Zhang L; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Zheng MQ; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Holden D; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Fowles K; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Ropchan J; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Nabulsi N; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
De Feyter H; Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
Carson RE; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Huang Y; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA.
Cai Z; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520-8048, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2081-2099. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/diagnostic imaging
Glioblastoma*/metabolism
Rats ; Animals ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/metabolism ; Tissue Distribution ; Brain/diagnostic imaging ; Brain/metabolism ; Positron-Emission Tomography/methods ; Primates
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Autorzy:
Miedema IHC; Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
Huisman MC; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
Zwezerijnen GJC; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
Grempler R; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
Pitarch AP; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88400, Biberach and der Riss, Germany.
Thiele A; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88400, Biberach and der Riss, Germany.
Hesse R; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88400, Biberach and der Riss, Germany.
Elgadi M; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
Peltzer A; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88400, Biberach and der Riss, Germany.
Vugts DJ; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
van Dongen GAMS; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
de Gruijl TD; Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Cancer Biology and Immunology, Cancer Center Amsterdam, De Boelelaan 1117, 1018 HV, Amsterdam, the Netherlands.
Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. .; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. .
Bahce I; Imaging and Biomarkers, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.; Department of Pulmonary Medicine, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2068-2080. Date of Electronic Publication: 2023 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/diagnostic imaging
Humans ; Radioisotopes ; Squamous Cell Carcinoma of Head and Neck ; Positron-Emission Tomography/methods ; Zirconium ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [ F]FDG-PET/CT parameters.
Autorzy:
Rogasch JMM; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. .; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany. .
Michaels L; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Baumgärtner GL; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Frost N; Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Rückert JC; Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Neudecker J; Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Ochsenreither S; Department of Hematology and Medical Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charité Comprehensive Cancer Center, Berlin, Germany.
Gerhold M; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Schmidt B; Department of Internal Medicine - Pneumology and Sleep Medicine, DRK Kliniken Berlin Mitte, Berlin, Germany.
Schneider P; Department of Thoracic Surgery, DRK Kliniken Berlin Mitte, Berlin, Germany.
Amthauer H; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Furth C; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Penzkofer T; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2140-2151. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Mediastinum/diagnostic imaging ; Positron Emission Tomography Computed Tomography/methods ; Fluorodeoxyglucose F18 ; Lymphatic Metastasis/diagnostic imaging ; Lymphatic Metastasis/pathology ; Retrospective Studies ; Lymph Nodes/pathology ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[ F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review.
Autorzy:
Timmers ER; Department of Neurology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands.; Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Klamer MR; Department of Neurology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands.; Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Marapin RS; Department of Neurology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands.; Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Lammertsma AA; Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen (UMCG), University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
de Jong BM; Department of Neurology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Dierckx RAJO; Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen (UMCG), University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Tijssen MAJ; Department of Neurology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, the Netherlands. .; Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, 9700 RB, Groningen, the Netherlands. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 1954-1973. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Chorea*/diagnostic imaging
Dystonia*
Tics*
Myoclonus*
Movement Disorders*/diagnostic imaging
Humans ; Fluorodeoxyglucose F18 ; Tremor ; Hyperkinesis ; Ataxia ; Glucose/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer.
Autorzy:
Li R; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
He H; Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 214000, China.
Li X; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
Zheng X; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
Li Z; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
Zhang H; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
Ye J; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
Zhang W; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China.
Yu C; Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 214000, China. .
Feng G; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China. .
Fan W; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou , 510060, Guangdong, People's Republic of China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2100-2113. Date of Electronic Publication: 2023 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/diagnostic imaging
Thyroid Neoplasms*/therapy
Surgery, Computer-Assisted*
Humans ; Animals ; Mice ; Fibronectins/metabolism ; Positron-Emission Tomography ; Peptides ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies.
Autorzy:
Privé BM; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands. .; Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands. .
Boussihmad MA; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Timmermans B; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
van Gemert WA; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Peters SMB; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Derks YHW; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
van Lith SAM; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Heskamp S; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Westdorp H; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 1906-1918. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Membrane Proteins*/metabolism
Radioisotopes*/therapeutic use
Humans ; Cell Line, Tumor ; Protein Transport ; Fibroblasts/metabolism ; Positron Emission Tomography Computed Tomography ; Gallium Radioisotopes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings.
Autorzy:
Sathekge M; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa. .; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa. .
Bruchertseifer F; European Commission, Joint Research Centre, Karlsruhe, Germany.
Vorster M; Department of Nuclear Medicine, University of Kwa-Zulu Natal & Inkosi Albert Luthuli Central Academic Hospital, Durban, South Africa.
Lawal IO; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa.
Mokoala K; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa.
Reed J; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa.
Maseremule L; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa.
Ndlovu H; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa.
Hlongwa K; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa.
Maes A; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Katholieke University Leuven, Kortrijk, Belgium.
Morgenstern A; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; European Commission, Joint Research Centre, Karlsruhe, Germany.
Van de Wiele C; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, 0001, South Africa.; Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2210-2218. Date of Electronic Publication: 2023 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*
Prostatic Neoplasms, Castration-Resistant*/radiotherapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Humans ; Male ; Prospective Studies ; Prostate/pathology ; Prostate-Specific Antigen/therapeutic use ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 6808

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies